Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CINJALL: Treatment for Children With ALL
NCT00176462Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Feb 2001
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of aminopterin in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Rutgers University. Primary endpoint: Relapse-free Survival at 5 years. Started Feb 2001; status: completed.
02
Drugs
aminopterin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00176462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176462.